Profile - To The Moon

Wilon

慢慢变富

Posts · 78Posts · 78
Following · 0Following · 0
Followers · 0Followers · 0

- WilonWilon
  ·2020-10-03
  666
  U.S. biotech company says it will provide experimental antibody treatment to Trump
  “再生元”公司（资料图）据美国有线电视新闻网（CNN）刚刚消息，当地时间2日，美国生物技术公司“再生元”（Regeneron）向已被确诊感染新冠肺炎的美国总统特朗普提供了一剂量的试验性抗体治疗。该公
  U.S. biotech company says it will provide experimental antibody treatment to Trump
  1.88K Comment
  Like
  Share
  Report

Most Discussed

{"i18n":{"language":"en_US"},"isCurrentUser":false,"userPageInfo":{"id":"3560726333195306","uuid":"3560726333195306","gmtCreate":1597633062163,"gmtModify":1706620737177,"name":"Wilon","pinyin":"wilon","introduction":"","introductionEn":"","signature":"慢慢变富","avatar":"https://static.tigerbbs.com/a5f6c20b0d5cf8e341581abf0647172e","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":5,"headSize":89,"tweetSize":78,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":3,"name":"书生虎","nameTw":"書生虎","represent":"努力向上","factor":"发布10条非转发主帖,其中5条获得他人回复或点赞","iconColor":"3C9E83","bgColor":"A2F1D9"},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.40%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.30","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"7a9f168ff73447fe856ed6c938b61789-1","templateUuid":"7a9f168ff73447fe856ed6c938b61789","name":"Knowledgeable Investor","description":"Traded more than 10 stocks","bigImgUrl":"https://static.tigerbbs.com/e74cc24115c4fbae6154ec1b1041bf47","smallImgUrl":"https://static.tigerbbs.com/d48265cbfd97c57f9048db29f22227b0","grayImgUrl":"https://static.tigerbbs.com/76c6d6898b073c77e1c537ebe9ac1c57","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1102},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"80.83%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":5,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":3,"crmLevelSwitch":0,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"page":1,"watchlist":null,"tweetList":[{"id":977486860,"gmtCreate":1601691429150,"gmtModify":1705067906035,"author":{"id":"3560726333195306","authorId":"3560726333195306","name":"Wilon","avatar":"https://static.tigerbbs.com/a5f6c20b0d5cf8e341581abf0647172e","crmLevel":3,"crmLevelSwitch":0,"followedFlag":false,"idStr":"3560726333195306","authorIdStr":"3560726333195306"},"themes":[],"htmlText":"666","listText":"666","text":"666","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/977486860","repostId":"1168028658","repostType":2,"repost":{"id":"1168028658","kind":"news","pubTimestamp":1601689815,"share":"https://ttm.financial/m/news/1168028658?lang=en_US&edition=fundamental","pubTime":"2020-10-03 09:50","market":"us","language":"zh","title":"U.S. biotech company says it will provide experimental antibody treatment to Trump","url":"https://stock-news.laohu8.com/highlight/detail?id=1168028658","media":"环球网","summary":"“再生元”公司（资料图）\n据美国有线电视新闻网（CNN）刚刚消息，当地时间2日，美国生物技术公司“再生元”（Regeneron）向已被确诊感染新冠肺炎的美国总统特朗普提供了一剂量的试验性抗体治疗。该公","content":"<p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25b12787e18a57cac6c77a2b76b7195b\" tg-width=\"2500\" tg-height=\"1667\"><span>\"Regeneration\" Company (data map)</span></p><p>According to news from CNN, on the 2nd local time, the American biotechnology company \"Regeneron\" provided a dose of experimental antibody treatment to US President Trump who has been diagnosed with novel coronavirus pneumonia. Leonard Shriver, CEO of the company, described Trump as now in a \"race\" with Novel Coronavirus, and if the virus wins, it may have \"dire consequences\".</p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b542d61403030e934ec0ebb0eaaa39f8\" tg-width=\"1376\" tg-height=\"279\"><span>CNN: \"Regeneron\" CEO says Trump is \"racing\" against the virus</span></p><p>\"His (Trump's) immune system is in a race against the virus, and if the virus wins, obviously, that could have dire consequences, and what our antibodies have to offer is to make this race play fairly,\" Shriver said in an interview with CNN.</p><p>\"Because of (Trump's) older age, and a whole host of other reasons, he's in the high-risk group, and we want to boost his immune system by giving him antibodies so he can win this race and make a full recovery,\" Shriver continued.</p>","source":"hqw","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>U.S. biotech company says it will provide experimental antibody treatment to Trump</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nU.S. biotech company says it will provide experimental antibody treatment to Trump\n</h2>\n<h4 class=\"meta\">\n<p class=\"head\">\n<strong class=\"h-name small\">环球网</strong><span class=\"h-time small\">2020-10-03 09:50</span>\n</p>\n</h4>\n</header>\n<article>\n<p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/25b12787e18a57cac6c77a2b76b7195b\" tg-width=\"2500\" tg-height=\"1667\"><span>\"Regeneration\" Company (data map)</span></p><p>According to news from CNN, on the 2nd local time, the American biotechnology company \"Regeneron\" provided a dose of experimental antibody treatment to US President Trump who has been diagnosed with novel coronavirus pneumonia. Leonard Shriver, CEO of the company, described Trump as now in a \"race\" with Novel Coronavirus, and if the virus wins, it may have \"dire consequences\".</p><p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/b542d61403030e934ec0ebb0eaaa39f8\" tg-width=\"1376\" tg-height=\"279\"><span>CNN: \"Regeneron\" CEO says Trump is \"racing\" against the virus</span></p><p>\"His (Trump's) immune system is in a race against the virus, and if the virus wins, obviously, that could have dire consequences, and what our antibodies have to offer is to make this race play fairly,\" Shriver said in an interview with CNN.</p><p>\"Because of (Trump's) older age, and a whole host of other reasons, he's in the high-risk group, and we want to boost his immune system by giving him antibodies so he can win this race and make a full recovery,\" Shriver continued.</p>\n<div class=\"bt-text\">\n\n\n<p> source：<a href=\"https://world.huanqiu.com/article/408BOT91CZ2\">环球网</a></p>\n\n\n</div>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"https://static.tigerbbs.com/25b12787e18a57cac6c77a2b76b7195b","relate_stocks":{"REGN":"再生元制药公司"},"source_url":"https://world.huanqiu.com/article/408BOT91CZ2","is_english":false,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1168028658","content_text":"“再生元”公司（资料图）\n据美国有线电视新闻网（CNN）刚刚消息，当地时间2日，美国生物技术公司“再生元”（Regeneron）向已被确诊感染新冠肺炎的美国总统特朗普提供了一剂量的试验性抗体治疗。该公司的首席执行官伦纳德·施莱弗形容称，特朗普现在正与新冠病毒“赛跑”，如果病毒获胜，可能会产生“可怕的后果”。\nCNN：“再生元”公司CEO说特朗普正与病毒“赛跑”\n施莱弗在接受CNN采访时说：“他（特朗普）的免疫系统正在与病毒赛跑，如果病毒获胜，显然，这可能会产生可怕的后果，而我们的抗体能提供的就是让这场比赛公平地进行。”\n“由于（特朗普）年龄较大，以及一系列其他原因，他属于高危人群，我们希望通过给他注射抗体来提振他的免疫系统，这样他就能赢得这场比赛，并完全康复。”施莱弗继续说。","news_type":1,"symbols_score_info":{"REGN":0.9}},"isVote":1,"tweetType":1,"viewCount":1879,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"defaultTab":"posts","isTTM":true}